427 related articles for article (PubMed ID: 17395769)
21. Human bone marrow-derived mesenchymal stromal cells expressing S-TRAIL as a cellular delivery vehicle for human glioma therapy.
Menon LG; Kelly K; Yang HW; Kim SK; Black PM; Carroll RS
Stem Cells; 2009 Sep; 27(9):2320-30. PubMed ID: 19544410
[TBL] [Abstract][Full Text] [Related]
22. Decrease of endogenous vascular endothelial growth factor may not affect glioma cell proliferation and invasion.
Hong X; Jiang F; Kalkanis SN; Zhang ZG; Zhang X; Zheng X; Mikkelsen T; Jiang H; Chopp M
J Exp Ther Oncol; 2007; 6(3):219-29. PubMed ID: 17552362
[TBL] [Abstract][Full Text] [Related]
23. Role of reactive oxygen species (ROS), metalloproteinase-2 (MMP-2) and interleukin-6 (IL-6) in direct interactions between tumour cell spheroids and endothelial cell monolayer.
Paduch R; Walter-Croneck A; Zdzisińska B; Szuster-Ciesielska A; Kandefer-Szerszeń M
Cell Biol Int; 2005 Jul; 29(7):497-505. PubMed ID: 15893483
[TBL] [Abstract][Full Text] [Related]
24. Erythropoietin, a hypoxia-regulated factor, elicits a pro-angiogenic program in human mesenchymal stem cells.
Zwezdaryk KJ; Coffelt SB; Figueroa YG; Liu J; Phinney DG; LaMarca HL; Florez L; Morris CB; Hoyle GW; Scandurro AB
Exp Hematol; 2007 Apr; 35(4):640-52. PubMed ID: 17379074
[TBL] [Abstract][Full Text] [Related]
25. IL-17 stimulates the proliferation and differentiation of human mesenchymal stem cells: implications for bone remodeling.
Huang H; Kim HJ; Chang EJ; Lee ZH; Hwang SJ; Kim HM; Lee Y; Kim HH
Cell Death Differ; 2009 Oct; 16(10):1332-43. PubMed ID: 19543237
[TBL] [Abstract][Full Text] [Related]
26. Immunohistochemical expression of stem cell, endothelial cell, and chemosensitivity markers in primary glioma spheroids cultured in serum-containing and serum-free medium.
Christensen K; Aaberg-Jessen C; Andersen C; Goplen D; Bjerkvig R; Kristensen BW
Neurosurgery; 2010 May; 66(5):933-47. PubMed ID: 20404698
[TBL] [Abstract][Full Text] [Related]
27. Human mesenchymal stem cells-like cells as cellular vehicles for delivery of immunotoxin in vitro.
Hu CC; Ke YQ; Sun XL; Jiang XD; Xu RX; Lv J; Wang YS; Cai YQ; Qin LS; Zou YX
Biotechnol Lett; 2009 Feb; 31(2):181-9. PubMed ID: 18923908
[TBL] [Abstract][Full Text] [Related]
28. Angiogenic CXC chemokine expression during differentiation of human mesenchymal stem cells towards the osteoblastic lineage.
Bischoff DS; Zhu JH; Makhijani NS; Kumar A; Yamaguchi DT
J Cell Biochem; 2008 Feb; 103(3):812-24. PubMed ID: 17583554
[TBL] [Abstract][Full Text] [Related]
29. Human mesenchymal stem cells play a dual role on tumor cell growth in vitro and in vivo.
Tian LL; Yue W; Zhu F; Li S; Li W
J Cell Physiol; 2011 Jul; 226(7):1860-7. PubMed ID: 21442622
[TBL] [Abstract][Full Text] [Related]
30. Mesenchymal stem cells induce endothelial activation via paracine mechanisms.
Ladage D; Brixius K; Steingen C; Mehlhorn U; Schwinger RH; Bloch W; Schmidt A
Endothelium; 2007; 14(2):53-63. PubMed ID: 17497361
[TBL] [Abstract][Full Text] [Related]
31. Quantifying in vitro growth and metabolism kinetics of human mesenchymal stem cells using a mathematical model.
Higuera G; Schop D; Janssen F; van Dijkhuizen-Radersma R; van Boxtel T; van Blitterswijk CA
Tissue Eng Part A; 2009 Sep; 15(9):2653-63. PubMed ID: 19207045
[TBL] [Abstract][Full Text] [Related]
32. Cytokine secretion by human mesenchymal stem cells cocultured with damaged corneal epithelial cells.
Oh JY; Kim MK; Shin MS; Wee WR; Lee JH
Cytokine; 2009 Apr; 46(1):100-3. PubMed ID: 19223198
[TBL] [Abstract][Full Text] [Related]
33. Breast cancer cell-derived fibroblast growth factor 2 and vascular endothelial growth factor are chemoattractants for bone marrow stromal stem cells.
Ritter E; Perry A; Yu J; Wang T; Tang L; Bieberich E
Ann Surg; 2008 Feb; 247(2):310-4. PubMed ID: 18216538
[TBL] [Abstract][Full Text] [Related]
34. ATP modulates cell proliferation and elicits two different electrophysiological responses in human mesenchymal stem cells.
Coppi E; Pugliese AM; Urbani S; Melani A; Cerbai E; Mazzanti B; Bosi A; Saccardi R; Pedata F
Stem Cells; 2007 Jul; 25(7):1840-9. PubMed ID: 17446563
[TBL] [Abstract][Full Text] [Related]
35. Early cellular changes of human mesenchymal stem cells and their interaction with other cells.
Akino K; Mineda T; Akita S
Wound Repair Regen; 2005; 13(4):434-40. PubMed ID: 16008733
[TBL] [Abstract][Full Text] [Related]
36. NF-kappaB downregulation may be involved the depression of tumor cell proliferation mediated by human mesenchymal stem cells.
Qiao L; Zhao TJ; Wang FZ; Shan CL; Ye LH; Zhang XD
Acta Pharmacol Sin; 2008 Mar; 29(3):333-40. PubMed ID: 18298898
[TBL] [Abstract][Full Text] [Related]
37. Human mesenchymal stem cells (hMSCs) target osteosarcoma and promote its growth and pulmonary metastasis.
Xu WT; Bian ZY; Fan QM; Li G; Tang TT
Cancer Lett; 2009 Aug; 281(1):32-41. PubMed ID: 19342158
[TBL] [Abstract][Full Text] [Related]
38. Human mesenchymal stem cells as a stable source of VEGF-producing cells.
Kagiwada H; Yashiki T; Ohshima A; Tadokoro M; Nagaya N; Ohgushi H
J Tissue Eng Regen Med; 2008 Jun; 2(4):184-9. PubMed ID: 18452238
[TBL] [Abstract][Full Text] [Related]
39. Suppression of tumorigenesis by human mesenchymal stem cells in a hepatoma model.
Qiao L; Xu Z; Zhao T; Zhao Z; Shi M; Zhao RC; Ye L; Zhang X
Cell Res; 2008 Apr; 18(4):500-7. PubMed ID: 18364678
[TBL] [Abstract][Full Text] [Related]
40. In vitro analysis of the interactions between preadipocytes and endothelial cells in a 3D fibrin matrix.
Borges J; Müller MC; Momeni A; Stark GB; Torio-Padron N
Minim Invasive Ther Allied Technol; 2007; 16(3):141-8. PubMed ID: 17573618
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
